[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-358972-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-358972-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","bub1-promotes-cell-stem-like-properties-and-serves-as-a-diagnostic-biomarker-for-lung-cancer","BUB1 promotes cell stem-like properties and serves as a diagnostic biomarker for lung cancer","","Cancer stem-like properties in tumor cells drive limited therapeutic efficacy and poor five-year survival in lung cancer. To improve diagnosis, prognosis evaluation, and treatment selection, weighted gene co-expression network analysis and Venn analysis were used to identify BUB1 as a key stemness-associated gene. Lung cancer tissues showed a markedly elevated mRNA stemness index, with BUB1 as a hub gene. BUB1 expression was upregulated and provided strong diagnostic performance in ROC analyses, and higher levels predicted worse LUAD survival. BUB1 knockdown suppressed stem-like traits, including sphere formation and stemness markers, via IL-17 signaling inactivation, and docking suggested actionable drug candidates.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/bub1-promotes-cell-stem-like-properties-and-serves-as-a-diagnostic-biomarker-for-lung-cancer/358972/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/bub1-promotes-cell-stem-like-properties-and-serves-as-a-diagnostic-biomarker-for-lung-cancer/358972.png","ImageObject",300,407,{"name":42,"@type":43},"River Wang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are stemness-associated biomarkers important in lung cancer?","Question",{"text":63,"@type":64},"Cancer cells with stem-like properties contribute to poor therapeutic outcomes and survival. Identifying stemness-associated biomarkers supports improved diagnosis, prognosis evaluation, and treatment selection for lung cancer patients.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was BUB1 identified in the study?",{"text":68,"@type":64},"Weighted gene co-expression network analysis and Venn analysis were used to identify BUB1 as a key stemness-associated gene, linked to stemness-related modules.",{"name":70,"@type":61,"acceptedAnswer":71},"What is the proposed mechanism by which BUB1 affects lung cancer stem-like properties?",{"text":72,"@type":64},"BUB1 knockdown suppressed stem-like features by reducing tumor sphere formation and downregulating stemness markers through inactivation of the IL-17 signaling pathway.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},358972,1790931145,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nBUB1 promotes cell stemlike properties and serves as a diagnostic biomarker for lung cancer  \nMulin Liu1,3, Siqi Zhu1,3, Qin Zheng2, Dapeng Ding1􀀍 & Shijun Li1􀀍  \nCancer cells with stem-like properties are major contributors to limited therapeutic efficacy and poor five-year survival rates. The identification of stemness-associated biomarkers is critical for improving diagnosis, prognosis evaluation, and treatment selection in lung cancer patients. Here, we employed weighted gene co-expression network analysis (WGCNA) and Venn analysis to identify BUB1 as a key stemness-associated gene. Our results revealed a significantly elevated mRNA stemness index (mRNAsi) in lung cancer tissues, with BUB1 as a hub gene in stemness-related modules. Clinically, BUB1 expression was markedly upregulated in lung cancer and demonstrated excellent diagnostic value, showing high area under the curve (AUC), sensitivity and specificity in ROC analysis. Elevated BUB1 expression strongly predicted poorer survival outcomes in LUAD patients. Mechanistically, BUB1 knockdown suppressed stem-like features, reducing tumor sphere formation and downregulating stemness markers through inactivation of the IL-17 signaling pathway. Molecular docking identified three potential BUB1-targeting drugs (quercetin, cryptolepine, etoposide) with stable binding conformations. Collectively, our fingdings established BUB1 as a diagnostic biomarker for lung cancer, an independent prognostic indicator for LUAD, and a promising therapeutic target, with its inhibition potentially overcoming CSCs-driven treatment resistance.  \nKeywords Lung cancer, BUB1, Stemness, Biomarker  \nLung cancer, one of the most prevalent and lethal malignancies, is the leading cause of cancer-related mortality worldwide, owing to its high incidence, mortality and recurrence rates1–3. Histologically, lung cancer is classified into two major subtypes: small cell lung cancer (SCLC), accounting for 15%, and non-small cell lung cancer (NSCLC), constituting nearly 85% of all cases4,5. NSCLC is further subdivided into lung squamous cell carcinoma (LUSC), lung adenocarcinoma (LUAD) and large cell carcinoma (LCC) . Due to the lack of sensitive and specific diagnostic markers, as well as non-specific symptoms, most patients are diagnosed at intermediate or advanced stages, complicating treatment and reducing the likelihood of a cure. Current clinical management relies on surgical resection, supplemented by preoperative or postoperative adjuvant therapies, including chemotherapy, radiotherapy, immunotherapy and molecular targeted therapy. Despite significant advancements in treatment modalities and improved outcomes, metastasis and treatment-associated toxicities continue to hinder the five-year survival rate. Therefore, identifying reliable biomarkers for early detection, survival assessment, and targeted therapy remains a critical unmet need in clinical decision-making.  \nCancer stem cells (CSCs) represent a clinically important subpopulation that drives tumor progression through their capabilities for self-renewal, immune evasion, and therapeutic resistance6–8. These properties make CSCs key contributors to tumor growth, metastasis, recurrence, drug resistance and ultimate treatment failure9–13. Targeting CSCs has consequently emerged as a transformative strategy across cancer types, with several promising approaches recently demonstrated. Important advances included the work of Li B et al. showing that all-trans retinoic acid reduced CSCs stemness while simutaneously improving the stem cell-enriched microenvironment, creating synergistic effects that inhibited tumor growth and metastasis14. In prostate cancer, Hsu CC et al. identified IMPDH2 as a crucial inositol sensor that maintained prostate CSCs and mediated resistance to castration therapy and androgen ablation15. Similarly, Wei JR et al. revealed how QSOX1 promoted  \n1Depar","cbCaippeoq0jRx2z","https://ap.wps.com/l/cbCaippeoq0jRx2z","pdf",10973859,16,"English","# Background\n## Clinical need for biomarkers in lung cancer\n## Cancer stem cells and therapeutic resistance\n# Study approach and analyses\n## WGCNA and Venn analysis to identify BUB1\n## Stemness index and hub gene identification\n# Results\n## Diagnostic value via ROC performance\n## Prognostic value in LUAD survival\n## Mechanistic role of BUB1 and IL-17 signaling\n## Therapeutic targeting candidates from molecular docking","[{\"question\":\"Why are stemness-associated biomarkers important in lung cancer?\",\"answer\":\"Cancer cells with stem-like properties contribute to poor therapeutic outcomes and survival. Identifying stemness-associated biomarkers supports improved diagnosis, prognosis evaluation, and treatment selection for lung cancer patients.\"},{\"question\":\"How was BUB1 identified in the study?\",\"answer\":\"Weighted gene co-expression network analysis and Venn analysis were used to identify BUB1 as a key stemness-associated gene, linked to stemness-related modules.\"},{\"question\":\"What is the proposed mechanism by which BUB1 affects lung cancer stem-like properties?\",\"answer\":\"BUB1 knockdown suppressed stem-like features by reducing tumor sphere formation and downregulating stemness markers through inactivation of the IL-17 signaling pathway.\"}]","BUB1 promotes cell stem-like properties and serves as a diagnostic biomarker for lung cancer | PDF",1790135771,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f55c8580d8abf86ea1a028ff34a76725.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e522e7220996731f162e98d2dda16c6a.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a5f7bbf4aba4e2c4b0efc305fca601ab.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4b3b6b9af73de7751332093951035e20.webp",980,1287]